UK R&D firm Futura Medical has cleared the first hurdle on the way to gaining US Food and Drug Administration approval for its drug-free erectile dysfunction gel MED3000 as an OTC medical device.
In a pre-submission meeting last year, the FDA agreed that Futura can make an application for a de novo classification...